v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 8,360 $ 8,482
Accounts receivable 0 1,253
Other current assets 3,813 2,477
Total current assets 12,173 12,212
Property and equipment, net 55 73
Operating lease assets 6,879 7,064
Other assets 890 886
Total assets 19,997 20,235
Current liabilities:    
Accounts payable 637 127
Accrued compensation 629 1,271
Accrued research and development expenses 41 82
Deferred revenue 684 716
Liability related to the sale of future revenues - current portion 715 9,750
Other current liabilities 2,939 2,976
Total current liabilities 5,645 14,922
Operating lease liabilities - long-term 9,076 9,347
Liability related to the sale of future revenues - long-term 40,759 32,673
Other long-term liabilities 1,829 1,795
Total liabilities 57,309 58,737
Commitments and contingencies (Note 9)
Stockholders' equity (deficit):    
Common stock - $0.0001 par value, 500,000 shares authorized as of March 31, 2026 and December 31, 2025; 8,512 and 7,324 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively 1 1
Additional paid-in capital 1,988,697 1,983,361
Accumulated other comprehensive income (loss) 0 1
Accumulated deficit (2,026,010) (2,021,865)
Total stockholders' equity (deficit) (37,312) (38,502)
Total liabilities and stockholders' equity (deficit) $ 19,997 $ 20,235

Source

10-Q
HTML PDF
XBRL
ZIP